Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00704
Species: Homo sapiens
Position : chr9:21980404-21981404
Year: 2023
Title: Identification and functional validation of an enhancer variant in the 9p213 locus associated with glaucoma risk and elevated expression of p16INK4a
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: cervical cancer
PMID:  37345431
MONDO: MONDO:0001156
Tissue: Cervix
Tissue Ontology ID: UBERON:0000002
Cell Source: HeLa
CVCL ID: CVCL_0030
Cell Type: cervical adenocarcinoma cell
Cell Ontology ID: CL:0000069
Experiment Type: Enhancer activity assay, TF binding assay, Functional perturbation assay
High Throughput Method:
Low Throughput Method: Luciferase Reporter Assay, EMSA, ChIP-RT-qPCR, RT-RT-qPCR
About Target Gene
Target gene : CDKN2A
About TF
TF name : YY1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
YY1 Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
YY1 DNA Damage Recognition in GG-NER reactome 38
YY1 E2F transcription factor network pid 77
YY1 mTOR signaling pathway pid 66
YY1 Notch-mediated HES/HEY network pid 48
YY1 Notch netpath 76
YY1 Notch signaling pathway pid 58
YY1 p53 pathway pid 59
YY1 Signaling events mediated by HDAC Class I pid 89
Enhancer Associated Network
Overlapping Enhancers (hg19) 5 found
Enhancer ID Position Tissue Cell Disease
E_01222 chr9:21978000-21983000 Lung fetal lung fibroblast --
E_00703 chr9:21980404-21981404 Brain neural stem cell --
E_00705 chr9:21980404-21981404 Lung fetal lung fibroblast --
E_00706 chr9:21980404-21981404 Breast breast carcinoma cell breast carcinoma
E_00707 chr9:21980404-21981404 Embryonic Kidney embryonic kidney cell --
Expression of Target Genes for the Enhancer